User:Dileep D. Monie: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
mNo edit summary |
mNo edit summary |
||
| (22 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
--> | --> | ||
*Dileep | *Dileep Monie | ||
* | *Immunologist | Bioengineer | Entrepreneur | ||
*Baltimore, MD, USA | *Baltimore, MD, USA | ||
*[http://www.linkedin.com/in/dmonie Connect with me on LinkedIn] | |||
*[[Special:Emailuser/Dileep D. Monie|Email me through OpenWetWare]] | *[[Special:Emailuser/Dileep D. Monie|Email me through OpenWetWare]] | ||
I learned about [[OpenWetWare]] from the [http://events.ccc.de/congress/2007/Fahrplan/events/2329.en.html 24C3 Endy lecture], and I've joined because I am interested in contributing to the [[The_BioBricks_Foundation:Standards/Technical|BBF Technical Standards]]. | |||
<!-- | |||
==Research Interests== | ==Research Interests== | ||
# Synthetic Biology | # Synthetic Biology | ||
## Standards - Establishing standards for biological parts to ensure interoperability and allow for construction of complex systems | ## [[The_BioBricks_Foundation:Standards/Technical|Standards]] - Establishing standards for biological parts to ensure interoperability and allow for construction of complex systems | ||
## Biocircuits - Implementing wetware abstraction layers to allow creation of devices for cellular computation and communications | |||
## Epigenetics - Manipulating chromatin structures with histone and DNA modifications as a form of biological software programming | ## Epigenetics - Manipulating chromatin structures with histone and DNA modifications as a form of biological software programming | ||
## | ## Delivery Systems - Making viruses or other vectors for targeted delivery of DNA parts into an established host genome | ||
# Bioengineering | # Bioengineering | ||
## Immunology - Defining the theoretical framework and designing components for an artificial immune system | ## Immunology - Defining the theoretical framework and designing components for an artificial immune system | ||
| Line 25: | Line 28: | ||
## Testing and Certification - Establishing an "Underwriters Laboratories" for developing standards and test procedures for biosafety | ## Testing and Certification - Establishing an "Underwriters Laboratories" for developing standards and test procedures for biosafety | ||
## Countermeasures - Designing fail-safe mechanisms to mitigate potential synthetic biology abuses | ## Countermeasures - Designing fail-safe mechanisms to mitigate potential synthetic biology abuses | ||
--> | |||
==BBF Contributions== | |||
* [[/Notebook/BBF_Standards_Measurement|Promoter Measurement Test]] | |||
== | ==OWW Brain Dump== | ||
* | *[[/Notebook|Notebook]] | ||
*[[/Recipes|Recipes]] | |||
*[http://openwetware.org/index.php?title=Special%3ALog&type=upload&user=Dileep+D.+Monie Upload log] | |||
==Publications== | ==Publications== | ||
<biblio> | <biblio> | ||
#Paper1 pmid= | #Paper1 pmid=10201994 | ||
#Paper2 pmid= | #Paper2 pmid=10441117 | ||
#Paper3 pmid=19298678 | |||
#Book1 isbn= | #Paper4 pmid=21212284 | ||
#Book1 isbn=9780781764964 | |||
// Contributed section on "Pulmonary Hypertension" (pp. 148-9) | |||
</biblio> | </biblio> | ||
Revision as of 08:06, 23 January 2013
Contact Info
- Dileep Monie
- Immunologist | Bioengineer | Entrepreneur
- Baltimore, MD, USA
- Connect with me on LinkedIn
- Email me through OpenWetWare
I learned about OpenWetWare from the 24C3 Endy lecture, and I've joined because I am interested in contributing to the BBF Technical Standards.
BBF Contributions
OWW Brain Dump
Publications
- Monday SR, Vath GM, Ferens WA, Deobald C, Rago JV, Gahr PJ, Monie DD, Iandolo JJ, Chapes SK, Davis WC, Ohlendorf DH, Schlievert PM, and Bohach GA. Unique superantigen activity of staphylococcal exfoliative toxins. J Immunol. 1999 Apr 15;162(8):4550-9.
- Vath GM, Earhart CA, Monie DD, Iandolo JJ, Schlievert PM, and Ohlendorf DH. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. Biochemistry. 1999 Aug 10;38(32):10239-46. DOI:10.1021/bi990721e |
- Kelly JR, Rubin AJ, Davis JH, Ajo-Franklin CM, Cumbers J, Czar MJ, de Mora K, Glieberman AL, Monie DD, and Endy D. Measuring the activity of BioBrick promoters using an in vivo reference standard. J Biol Eng. 2009 Mar 20;3:4. DOI:10.1186/1754-1611-3-4 |
- Oh U, McCormick MJ, Datta D, Turner RV, Bobb K, Monie DD, Sliskovic DR, Tanaka Y, Zhang J, Meshulam J, and Jacobson S. Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease. Blood. 2011 Mar 24;117(12):3363-9. DOI:10.1182/blood-2010-10-306571 |
- ISBN:9780781764964
Contributed section on "Pulmonary Hypertension" (pp. 148-9)
